Chapter 6. Influenza vaccine. Epidemic influenza;Capítulo 6. Vacunación antigripal. Gripe epidémica

Medicina Preventiva

Volumn 15, Issue 3, 2009, Pages 48-56

  Salleras, L ^a,b   Saenz M C ^c   Castrodeza, J ^d   De Juanes, J R ^e   Arrazola, M P ^e  

^a HOSPITAL CLÍNIC   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^d HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID   (Spain)

^e HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77949392774     PISSN: 11352841     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (91)

1. De Juanes JR. Influenza: key issues and immunisation. Chemist 2002;2:4-16.
2. Cox NJ, Subbarao K. Influenza. Lancet 1999;354:1277-82.
3. Salleras L, Domínguez A. Impacto sanitario y económico de la vacunación antigripal inactivada. Vacunas 2002;3 (supl. 1):38-46.
4. CDC. Prevention and Control of Influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2009;58:1-52.
5. a ed. New York: Churchill Livingstone, 1995; p. 1546-56.
6. a ed. Philadelphia: Churchill Livingstone, 2000; p. 1823-49.
7. CDC Prevention and Control of Influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2005;54(RR-8):1-40.
8. Glezen WP. Serious morbidity and mortality associated with influenza epidemics. Epidemiol Rev 1982;4:25-44.
9. Couch RB, Keitel WA, Cate TR et al. Prevention of influenza virus infections by current inactivated influenza virus infections by current inactivated influenza virus vaccines. En: Brown LE, Hampson AW, Webster RB, editors. Options for the Control of Influenza Amsterdam: Elsevier Science, 1996; p. 97-106.
10. Barker WH, Mullolly JP. Impact of epidemic type A influenza in a defined adult population. Am J Epidemiol 1980;112:798-811.
11. Simonsen L, Clarke MJ, Williamson GD, Stroup DF, Arden NH, Schonberger LB. Impact of influenza epidemics on mortality: introducing a severity index. Am J Public Health 1997;87:1944-50.
12. Simonsen L, Fukuda, K, Schonberger LB, Cox NJ. Impact of influenza epidemics on hospitalizations. J Infect Dis 2000;181:831-7.
13. Glezen WP, Decker M, Perrotta DM. Survey of underlying conditions of persons hospitalized with acute respiratory disease during influenza epidemics in Houston, 1978-1981. Am Rev Resp Dis 1987;136:550-5.
14. Eickhoff TC, Sherman IL, Serfling RE. Observations on excess mortality associated epidemic influenza. JAMA 1961;176:776-82.
15. Barker WH, Mullooly JP. Pneumonia and influenza deaths during epidemics: implications for prevention. Arch Intern Med 1982;142:85-9.
16. Lui K-J, Kendal AP. Impact of influenza epidemics on mortality in the United States from October 1972 to May 1985. Am J Public Health 1987;77:712-6.
17. Douglas RG. Prophylaxis and treatment of Influenza. N Engl J Med 1990;211:896-8.
18. Thompson WW, Shay DK, Weintraub E, Brammer L, Bridges CB, Cox NJ et al. Influenza-associated hospitalizations in the United States. JAMA. 2004;292:1333-40.
19. Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Anderson LJ et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003;289:179-86.
20. Kavet J. A perspective on the significance of pandemic influenza. Am J Public Health 1977;67:1063-70.
21. CDC. Prevention and Control of Influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2002;51 (RR-3):1-31.
22. Neuzil KM, Meilen BG, Wright PF, Mitchel EF Jr, Griffin MR. The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. N Engl J Med 2000;342:225-31.
23. Poland GA, Breese Hall C. Influenza immunization of schoolchildren: can we interrupt community epidemics? Pediatrics 1999;103:1280-2.
24. Bridges CB, Katz JM, Levandowski RA, Cox NJ. Inactivated Influenza Vaccines. In: Plotkin SA, Orenstein WA, Offit PA, ed. Vaccines 5th ed: Saunders-Elsevier, 2008.
25. CDC. Recommended Childhood and adolescent immunization schedule - United States, July-December 2004; MMWR 2004;53:Q1-Q3.
26. Quinnan GV, Schooley R, Dolin R, Ennis FA, Gross P, Gwaltney JM. Serologic responses and systemic reactions in adults after vaccination with monovalent A/USSR/77 and trivalent A/USSR/77, A/Texas/77, B/Hong Kong/72 influenza vaccines. Rev Infect Dis 1983;5:748-57.
27. Benne CA, Harmsen M, de Jong JC, Kraaijeveld CA. Neutralization enzyme immunoassay for influenza virus. J Clin Microbiol 1994;32:987-90.
28. Okuno Y, Tanaka K, Baba K, Maeda A, Kunita N, Ueda S. Rapid focus reduction neutralization test of influenza A and B viruses in microliter system. J Clin Microbiol 1990;28:1308-13.
29. Ennis FA, Rook AH, Qi YH, Schild GC, Riley D, Pratt R, Potter CW. HLA restricted virus-specific cytotoxic T-lymphocyte responses to live and inactivated influenza vaccines. Lancet 1981;2:887-81.
30. Powers DC. Influenza A virus-specific cytotoxic T lymphocyte activitydeclines with advancing age. J Am Geriatr Soc 1993;41:1-5.
31. Dowdle WR, Coleman MT, Mostow SR, Kaye HS, Schoenbaum SC. Inactivated influenza vaccines. 2. Laboratory indices of protection. Postgrad Med J 1973;49:159-63.
32. Hobson D, Curry RL, Beare AS, Ward-Gardner A. The role of serum haemagglutinin inhibition antibody in protection against challenge infection with A2 and B viruses. J Hyg 1972;70:767-77.
33. Davies JR, Grilli EA. Natural or vaccine-induced antibody as a predictor of immunity in the face of natural challenge with influenza viruses. Epidemiol Infect 1989;102:325-33.
34. Beyer WEP, Palache AM, Baljet M, Masurel N. Antibody induction by influenza vaccines in the elderly: A review of the literature. Vaccine 1989;7:385-94.
35. Palache AM, Beyer WE, Sprenger MJ, Masurel N, de Jonge S, Vardy A et al. Antibody response after influenza immunization with various vaccine doses: a double-blind, placebo-controlled, multi-centre, dose-response study in elderly nursing-home residents and young volunteers. Vaccine 1993;11:3-9.
36. a edición. Barcelona: Masson 2003; p. 321-62.
37. Belshe RB, Newman FK, Cannon J, Duanne C, Treanor J, Van Hoecke C et al. Serum antibody responses after intradermal vaccinatiohn against influenza. N Engl J Med 2004;351:2286-94.
38. Kemble G, Greenberg H. Novel generations of influenza vaccines. Vaccine 2003;21:1789-95.
39. Gluck R, Mischler R, Finkel B, Que JU, Scarpa B, Cryz SJ Jr. Immunogenicity of new virosome influenza vaccine in elderly people. Lancet 1994;344:160-3.
40. Huckriede A, Bungener L, Stegmann T, Daemen T, Medema J, Palache AM et al. The virosome concept for influenza vaccines. Vaccine 2005;23 (supp.1):S26-S38.
41. De Bruijn IA, Nauta J, Cramer WC, Gerez L, Palache AM. Clinical experience with inactivated, virosomal influenza vaccine. Vaccine 2005;23 (Suppl. 1):S39-S49.
42. Moser C, Metcalfe IC, Viret JF. Virosomal adjuvanted antigen delivery systems. Expert Rev Vaccines 2003;2:189-96.
43. Dooley M, Goa KL. Adjuvanted influenza vaccine. Biodrugs 2000;14:61-9.
44. Banzhoff A, Nacci P, Podda A. A new MF59-adjuvanted influenza vaccine enhances the immune response in the elderly with chronic diseases: Results from an immunogenicity metaanalysis. Gerontology 2003;49:177-84.
45. Baldo V, Menegon T, Bonello C, Floreani A, Trivello R. Comparison of three different influenza vaccines in institutionalised elderly. Vaccine 2001;19:3472-85.
46. Squarcione S, Sgricia S, Biasio LR, Perinetti E. Comparison of the reactogenicity and immunogenicity of a split and a subunit-adjuvanted influenza vaccine in elderly subjects. Vaccine 2003;21:1268-74.
47. Podda A. The adjuvanted influenza vaccines with novel adjuvants: experience with the MF59-adjuvanted vaccine. Vaccine 2001;19:2673-80.
48. Jefferson T, Rivetti D, Rivetti A, Rudin M, Di Pietrantoni C, Demicheli V. Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review. Lancet 2005;366:1165-74.
49. Nichol KL. Efficacy/clinical effectiveness of inactivated influenza virus vaccines in adults. En: Nicholson KG, Webster RG, Hay AS, editors. Testbook of Influenza. Oxford: Blackwell Science, 1998; p. 358-72.
50. Jefferson TO, Rivetti D, DiPietrantonj C, Rivetti A, Demicheli V. Vaccines for preventing influenza in healthy adults. Cochrane Database of Systematic Reviews 2007, Issue 2. Art. No.: CD001269. DOI:10.1002/14651858. CD001269.pub3.
51. Meiklejohn G. Viral respiratory disease at Lowry Air Force Base in Denver, 1952-1982. J Infect Dis 1983;148:775-84.
52. Edwards KM, Dupont WD, Westrich MK, Plummer WD Jr, Palmer PS, Wright PF. A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease. J Infect Dis 1994;169:68-76.
53. Nichol KL, Lind A, Margolis KL, Murdoch M, McFadden R, Hauge M et al. The effectiveness of vaccination against influenza in healthy, working adults. N Engl J Med 1995;33:889-93.
54. Wilde JA, McMillam JA, Serwint J, Butta J, O'Riordan MA, Steinhoff MC. Effectiveness of influenza vaccine in health care professionals: a randomized trial. JAMA 1999;282:908-13.
55. Bridges CB, Thompson WW, Meltzer MI, Reeve GR, Talamonti WJ, Cox NJ et al. Effectiveness and cost-benefit of influenza vaccination of healthy working adults: A randomized controlled trial. JAMA 2000;284:1655-63.
56. Grotto I, Mandel Y, Green MS, Varsano N, Gdalevich M, Ashkenazi I et al. Influenza vaccine efficacy in young, healthy adults. Clin Infect Dis 1998;26:213-7.
57. Saxen H, Virtanen M. Randomized, placebo-controlled double blind study on the efficacy of influenza immunization on absenteeism of health care workers. Ped Infect Dis J 1999;18:779-83.
58. Sandrini MC, Pregliasco F, Mensi C, Giardini G, Lucchi T, Santambrogio D et al. Valutazione dell'immunogenicita e dell'efficacia sul campo (stagione 1994-1995) del vaccino antifluenzale di anziani non instituzionalizzati. Annali Di Igiene 1997;9:373-9.
59. Nichol KL. Complications of influenza and benefits of vaccination. Vaccine 1999;17:S47-S52.
60. Mullooly J, Bennett M, Hornbrook M, Barker WH, Williams WW, Patriarca PA et al. Influenza vaccination programs for elderly persons: cost-effectiveness in a health maintenance organisation. Ann Intern Med 1994;121:947-52.
61. Lopez Hernandez B, Vazquez J, Fernandez E, Martinez B, Romero J, Arribas L. Efectividad de la vacunación antigripal en ancianos. Atención Primaria 1994;14:532-6.
62. Ahmed AE, Nicholson KG, Nguyen-Van-Tam JS. Reduction in mortality associated with influenza vaccine during the 1989-1990 epidemic. Lancet 1995;346:591-5.
63. Fedson DS, Wajda A, Nicol JP, Hammond GW, Raise DL, Roos LL. Clinical effectiveness of influenza vacciantion in Manitoba (published erratum appears in JAMA, 1994; 271: 1578). JAMA 1993;2720:1956-61.
64. Barker W, Mullooly J. Influenza vaccination of elderly persons. Reduction in pneumonia and in influenza hospitalization and deaths. JAMA 1980;244:2547-9.
65. Barker W, Raubertas R, Menegus M, O'Brien D, Freundlich C, Betts R. Case-control study of influenza vaccine effectiveness in preventing pneumonia hospitalization among older persons. En: Proceedings of the International Conference on Options for the Control of Influenza II. Monroe County, New York, 1989-1992, France: Courchevel, 1992.
66. Foster A, Talsma A, Furumoto-Dawson A, Ohmit SE, Margulies JR, Arden NA et al. Influenza vaccine effectiveness in preventing hospitalization for pneumonia in the elderly. Am J Epidemiol 1992;136:296-307.
67. Ohmit E, Monto S. Influenza vaccine effectiveness in preventing hospitalization among the elderly during influenza type A and type B seasons. Int J Epidemiol 1995;24:1240-8.
68. Puig-Barbera J, Marquez-Calderon S, Masoliver-Fores A, Lloria-Paes F, Ortega-Dicha A, Gil-Martin M et al. Reduction in hospital admissions for pneumonia in non-institutionalised elderly people as a result of influenza vaccination: a case-control study in Spain. J Epidemiol Community Health 1997;51:526-30.
69. Strikas R, Cook P, Kuller L, Talbott E, Plouffe J, File T et al. Case-control study in Ohio and Pennsylvania on prevention of hospitalisation by influenza vaccination York. En: Proceedings of the International Conference on Options for the Control of Influenza II. France: Courchevel, 1992.
70. Fleming DM, Watson JM, Nicholas S, Smith GE, Swan AV. Study of the effectiveness of influenza vaccination in the elderly in the epidemic of 1989-1990 using a general practice database. Epidemiol Infect 1995;115;581-9.
71. Monto AS, Hornbuckle K, Ohmit SE. Influenza vaccine effectiveness among elderly nursing home residents: A cohort study. Am J Epidemiol 2001;154:155-60.
72. Nordin J, Mullooly J, Poblete S, Strikas R, Petrucci R, Wei F et al. Influenza vaccine effectiveness in preventing hospitalizations and deaths in persons 65 years and older in Minnesota, New York, and Oregon: data from 3 health plans. J Infect Dis 2001;184:665-70.
73. Nichol KL, Nordin J, Mullooly J, Lask R, Killbrandt K, Iwane M. Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. N Engl J Med 2003;348:1322-32.
74. Puig-Barbera J, Diez-Domingo J, Perez-Hoyos S, Belenguer Varea A, Gonzalez Vidal D. Effectiveness of the MF59 adjuvanted influenza vaccine in preventing emergency admission for pneumonia in the elderly over 64 years of age. Vaccine 2004;23:283-9.
75. Iob A , Brianti G, Zamparo E, Gallo T. Evidence of increased clinical protection of an MF59-adjuvant influenza vaccine compared to a non-adjuvant vaccine among elderly residents of long-term care facilities in Italy. Epidemiol Infect 2005;133:687-93.
76. Nichol KL. Clinical effectiveness of influenza vaccine in community-living seniors. En: Brown LE, Hampson AW, Webster RG, editors. Options for the control of influenza. Vol 3. Amsterdam: Elsevier, 1996; p. 119-122.
77. Nichol KL. Influenza vaccination in the elderly. Impact of hospitalization and mortality. Drugs Aging 2005;22:495-515.
78. Nichol KL, Margolis KL, Wuorenma J, Von Stenberg T. The efficacy and cost-effectiveness of vaccination against influenza among elderly people living in the community. N Engl J Med 1994;331:778-84.
79. Gross A, Hermogenes W, Sacks S, Lau J, Levandowski A. The efficacy of influenza vaccine in elderly persons: a meta-analysis and review of the literature. Ann Intern Med 1995;123:518-27.
80. Vu T, Farish S, Jenkins M, Kelly H. A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the community. Vaccine 2002;20:1831-6.
81. Rivetti D, Jefferson T, Thomas R, Rudin M, Rivetti A, Di Pietrantonj et al. Vaccines for preventing influenza in the elderly. Cochrane Database Syst Rev. 2006;3:CD004876.
82. Jefferson T, Di Pietratonj C. Inactivated vaccines in the elderly - are you sure? Lancet 2007;370:1199-200.
83. Puig-Barbera J, Marquez Calderon S. Effectiveness of influenza vaccine in the elderly: a critical review of the bibliography (Spanish). Med Clin (Barc) 1995;105:645-8.
84. Simonsen L, Taylor RJ, Viboud C, Miller MA, Jackson LA. Mortality benefits of influenza vaccination in elderly people: an ongoing controversy. Lancet Infect Dis 2007;7:658-66.
85. Örquist ÄOrtqvist A, Granath F, Askling J, Hedlund J. Influenza vaccination and mortality: prospective cohort study of the elderly in a large geographical area. Eur Respir J 2007;30:414-22.
86. Nichol KL. Effectiveness of influenza vaccine in the Community-Dwelling elderly. N Engl J Med 2007;357:1373-81.
87. Nichol KL. Efficacy and effectiveness of influenza vaccination. Vaccine 2008;26 (suppl D):D17-22.
88. Singleton JA, Greby SM, Wooten KG, Walter FJ, Strikas R. Influenza, pneumococcal, and tetanus toxoid vaccination of adults - United States, 1993-1997. MMWR 2000;49 (Suppl 9):39-56.
89. Jiménez R, Larrauri A, Carrasco P, Esteban J, Gómez-López LL, Gil A. Influenza coverages in Spain and vaccination-related factors in the subgroup aged 50-64 years. Vaccine 2003;21:3550-5.
90. Jiménez R, Mayo E, Hernández V, Sierra MJ, Pachón I, Carrasco P et al. Evolution of anti-influenza vaccination coverage in Spain from 1993 to 2001. Vaccine 2005;23:2844-50.
91. Aballea S, Chancellor J, Martin M, Wutzler P, Carrat F, Gasparini R et al. Lowering the age threshold for routine influenza vaccination: an economic evaluation for four european countries. 2nd European Conference of Influenza. Malta 4-6 setember 2005.